Post-marketing surveillance of Vadadustat in patients with anemia in chronic kidney disease for long-term efficacy and safety
Not Applicable
- Conditions
- Renal anemia
- Registration Number
- JPRN-UMIN000042349
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients scheduled to undergo renal transplantation are excluded from the surveillance, but those registered on the waiting list for renal transplantation may be eligible
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety Occurrence of adverse events during the observation period Efficacy Time course of the hemoglobin level during the observation period
- Secondary Outcome Measures
Name Time Method